Black Titan Corporation
BTTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.39M
Close$
Share Statistics
| Market cap | $3.39 Million |
|---|---|
| Enterprise Value | $188,828.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $248.12 |
| Beta | 1.23 |
| Outstanding Shares | 1,000 |
Return
| Return on Equity | 5.67% |
|---|---|
| Return on Assets | 3.59% |
| Return on Invested Capital | 4.50% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | 0.56 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 3.87 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$-17.00
Average shareholder expectationRevenue Estimate
$960,000
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-7.00
Average shareholder expectationRevenue Estimate
$1.08 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5506.70%▲ 5491.15% |
|---|---|
| Total Invested | $77,089▼ 92.30% |
| Investors Holding | 11▼ 7.00% |
ESG Score
No data
About Black Titan Corporation
CEO: Weei Jye Chay Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquartered in Petaling Jaya, Malaysia.